Clinical trial

Antihypertensive Response to Losartan and Genetic Polymorphisms

NCT00617877

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-03-01

PhaseNA

Study timeline

Study start (unknown)2005-03-01Date precision: month

Registry last updated2009-07-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

losartan potassiumDRUG · verified · RxNorm: losartan potassium

Comparator: HydrochlorothiazideDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00617877 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.